title: The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
abstract: Evidence suggests that apoptosis of liver cells may play a significant role in the pathogenesis of hepatitis C virus (HCV) infection. One of the best characterized apoptotic pathway is that mediated by the death receptor Fas. Fas expression has been found to be up-regulated on hepatocytes in chronic HCV infection, particularly in periportal areas. Recently, two polymorphisms have been identified in the promotor region of the FAS gene, -1377G > A and -670A > G. We have evaluated the involvement of these variants in the susceptibility to HCV infection, the severity of liver damage and progression of fibrosis in chronic hepatitis C. A cohort of 197 patients with chronic hepatitis C and 100 controls were analysed for both polymorphisms by Fluorescence Resonance Energy Transfer using specific probes and the Lightcycler system. In addition, liver biopsies were taken in 167 patients and scored using the Knodell classification system. We have found that the allele frequencies and the distribution of both polymorphisms do not differ significantly in the HCV cohort and in the control population. Thus, none of the polymorphisms seems to be related with susceptibility to HCV infection. However, we have examined the possible association between the two variants and the grade of necroinflammatory activity and the stage of fibrosis and we have detected an under-representation of the -670A > G variant among those patients with higher Knodell's scores (P = 0.049) and necroinflammatory activity (P = 0.036). The -670A allele was associated with higher levels of periportal necrosis (P = 0.012). In conclusion, our findings suggest an association between the -670A > G polymorphism and the grade of necrosis in periportal areas in patients with chronic hepatitis C.
authors.affiliation: Servicio Aparato Digestivo, Sección de Hepatología, Hospitales Universitarios Virgen del Rocío, Sevilla, Spain. mruiz@hgmp.mrc.ac.uk
authors.forename: J
authors.initials: J
authors.lastname: Aguilar-Reina
authors.forename: M
authors.initials: M
authors.lastname: Ruiz-Ferrer
authors.forename: M A
authors.initials: MA
authors.lastname: Pizarro
authors.forename: G
authors.initials: G
authors.lastname: Antiñolo
mesh_terms: D000293:Adolescent; D000328:Adult; D017209:Apoptosis; D001483:Base Sequence; D005260:Female; D031541:Fluorescence Resonance Energy Transfer; D016174:Hepacivirus / Q000472:pathogenicity*; D019698:Hepatitis C, Chronic / Q000235:genetics / Q000503:physiopathology* / Q000821:virology; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009336:Necrosis; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry / Q000235:genetics*; D012720:Severity of Illness Index; D019014:fas Receptor
chemical_list: C491901:FAS protein, human; D018124:Receptors, Tumor Necrosis Factor; D019014:fas Receptor